At the recent NCPDP Joint Technical Work Group Meetings, held in Scottsdale in early May, the membership voted to approve…
The specialty pharmacy market continues to grow, and with 60% of the drugs in phase 3 clinical trials considered specialty…
At the recent NCPDP Joint Technical Work Group Meetings, held in Scottsdale in early May, the membership voted to approve…
The specialty pharmacy market continues to grow, and with 60% of the drugs in phase 3 clinical trials considered specialty…